Atlas Trials

Xeroderma Pigmentosum

10 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Xeroderma Pigmentosum

RecordFirmDate
A Study to Evaluate the Safety and Efficacy of Afamelanotide in Patients With Xeroderma Pigmentosum C and V (NCT05370235)Clinuvel Europe Limited2022-03-28
A Study to Evaluate the Safety and Efficacy of Afamelanotide in Patients With Xeroderma Pigmentosum (XP) (NCT05159752)Clinuvel Europe Limited2021-10-19
Testing the Combination of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) in Children, Adolescent, and Young Adult Patients With Relapsed/Refractory Cancers That Have an Increased Number of Genetic Changes, The 3CI Study (NCT04500548)National Cancer Institute (NCI)2021-05-11
XPAND Trial: Enhancing XP Photoprotection Activities - New Directions (NCT03445052)Guy's and St Thomas' NHS Foundation Trust2018-03-30
Xeroderma Pigmentosum Patient Experiences (NCT01123694)Henry Ford Health System2009-07-01
Use of an SPF30 Sunscreen and an After-sun-lotion in Skin Cancer Risk Patients (NCT00555633)Medical University of Graz2004-10-01
Cancer Risk in Carriers of the Gene for Xeroderma Pigmentosum (NCT00046189)National Cancer Institute (NCI)2003-04-07
Examination of Clinical and Laboratory Abnormalities in Patients With Defective DNA Repair: Xeroderma Pigmentosum, Cockayne Syndrome, or Trichothiodystrophy (NCT00001813)National Cancer Institute (NCI)1999-05-10

Track Xeroderma Pigmentosum automatically

Every clearance here is in the API, with alerts when new ones post.